(Q55898854)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Autosomal dominant polycystic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

autosomal dominant polycystic kidney disease

29 December 2019

main subject

0 references

autosomal dominant polycystic kidney

1 reference

Vicente E Torres

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Peter C Harris

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yves Pirson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

369

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1287-1301

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

9569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystic kidney disease: The complete structure of the PKD1 gene and its protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Analysis of the genomic sequence for the autosomal dominant polycystic kidney disease (PKD1) gene predicts the presence of a leucine-rich repeat. The American PKD1 Consortium (APKD1 Consortium)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Recurrent fetal loss associated with bilineal inheritance of type 1 autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Trans-heterozygous Pkd1 and Pkd2 mutations modify expression of polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Defining a link with autosomal-dominant polycystic kidney disease in mice with congenitally low expression of Pkd1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The Position of the Polycystic Kidney Disease 1 (PKD1) Gene Mutation Correlates with the Severity of Renal Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Comparison between siblings and twins supports a role for modifier genes in ADPKD.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Modifier genes play a significant role in the phenotypic expression of PKD1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

PKD1 interacts with PKD2 through a probable coiled-coil domain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mechanical stimuli induce cleavage and nuclear translocation of the polycystin-1 C terminus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin-1, STAT6, and P100 function in a pathway that transduces ciliary mechanosensation and is activated in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

A physiological view of the primary cilium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The centrosome in human genetic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mispolarization of desmosomal proteins and altered intercellular adhesion in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Identification and characterization of polycystin-2, the PKD2 gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin 2 interacts with type I inositol 1,4,5-trisphosphate receptor to modulate intracellular Ca2+ signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Specific association of the gene product of PKD2 with the TRPC1 channel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin-2 is an intracellular calcium release channel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

PKD2 interacts and co-localizes with mDia1 to mitotic spindles of dividing cells: role of mDia1 IN PKD2 localization to mitotic spindles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Functional properties of Ca2+-inhibitable type 5 and type 6 adenylyl cyclases and role of Ca2+ increase in the inhibition of intracellular cAMP content

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

[Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Genetics in kidney disease: how much do we want to know?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Autosomal Dominant Polycystic Kidney Disease Types 1 and 2: Assessment of US Sensitivity for Diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

An ultrasound renal cyst prevalence survey: specificity data for inherited renal cystic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Attitudes of at-risk and affected individuals regarding presymptomatic testing for autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

PGD for autosomal dominant polycystic kidney disease type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

A complete mutation screen of the ADPKD genes by DHPLC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Volume progression in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Water for ADPKD? Probably, yes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Increased water intake decreases progression of polycystic kidney disease in the PCK rat

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Long-term effects of vasopressin on the subcellular localization of ENaC in the renal collecting system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Contribution of vasopressin to progression of chronic renal failure: study in Brattleboro rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Renal ammonia in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Characteristics of hypertension in young adults with autosomal dominant polycystic kidney disease compared with the general U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Natriuretic response to volume expansion in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Renal structure and hypertension in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The anatomy of the renin-secreting cell in adult polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Analysis of the polycystins in aortic vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Pkd2+/- vascular smooth muscles develop exaggerated vasocontraction in response to phenylephrine stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Endothelial dysfunction and reduced nitric oxide in resistance arteries in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Flow-associated dilatory capacity of the brachial artery is intact in early autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Pain patterns in patients with polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Pain management in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Angiogenesis in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The Association of Nephrolithiasis and Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Renal stone disease in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Smoking--a renal risk factor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystic liver disease is genetically heterogeneous: clinical and linkage studies in eight Finnish families

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Clinical profile of autosomal dominant polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mutations in SEC63 cause autosomal dominant polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Estrogens and the pathophysiology of the biliary tree

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Hepatic cyst infection in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

High incidence of common bile duct dilatation in autosomal dominant polycystic kidney disease patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Adenoma of the ampulla of Vater: a genetic condition?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Intrahepatic cholangiocarcinoma arising in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The prevalence of seminal vesicle cysts in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Seminal vesicle cysts: association with adult polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Chronic subdural hematoma in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Intracranial cysts in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Familial arachnoid cysts in association with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Abdominal sonographic study of autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Infertility in adults with polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Assisted reproduction for infertile patients with 9 + 0 immotile spermatozoa associated with autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Recurrent pancreatitis in a patient with autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Pancreatic ductal adenocarcinoma associated with Potter type III cystic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Intraductal papillary mucinous tumor of the pancreas associated with autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Chronic subdural haematoma and autosomal polycystic kidney disease: report of two new cases

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Frequency of ovarian cysts in patients with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Ovarian manifestations in women with autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Echocardiographic Findings in Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Cardiovascular Abnormalities Associated with Adult Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Diverticular disease in patients with chronic renal failure due to polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Evaluation of colonic diverticular disease in autosomal dominant polycystic kidney disease without end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Duodenal diverticulosis in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Losartan, an angiotensin-II receptor antagonist, retards the progression of advanced renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

No effect of enalapril on progression in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Design and baseline characteristics of participants in the study of antihypertensive therapy in children and adolescents with autosomal dominant polycystic kidney disease (ADPKD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Hand-assisted laparoscopic nephrectomy in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Laparoscopic renal denervation for intractable ADPKD-related pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Thoracoscopic renal denervation for intractable autosomal dominant polycystic kidney disease-related pain

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Laparoscopic nephrectomy in patients with end-stage renal disease and autosomal dominant polycystic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Pretransplant Nephrectomy in Patients With Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Liver resection and cyst fenestration in the treatment of severe polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Management of polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

New advances in evaluation and management of patients with polycystic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Recurrence of intracranial aneurysms in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: a prospective ten-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): is there light at the end of the tunnel?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

Extracellular signal-regulated kinase inhibition slows disease progression in mice with polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960601-1

7 January 2021

10.1016/S0140-6736(07)60601-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17434405%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference